CN102670869A - Chinese medicine oral fluid containing cattail pollen for relieving hyperlipoidemia and preparing method thereof - Google Patents
Chinese medicine oral fluid containing cattail pollen for relieving hyperlipoidemia and preparing method thereof Download PDFInfo
- Publication number
- CN102670869A CN102670869A CN2012101821317A CN201210182131A CN102670869A CN 102670869 A CN102670869 A CN 102670869A CN 2012101821317 A CN2012101821317 A CN 2012101821317A CN 201210182131 A CN201210182131 A CN 201210182131A CN 102670869 A CN102670869 A CN 102670869A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine oral
- pollen
- oral liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title claims description 8
- 239000012530 fluid Substances 0.000 title abstract 3
- 240000001398 Typha domingensis Species 0.000 title 1
- 210000000582 semen Anatomy 0.000 claims abstract description 14
- 241000233948 Typha Species 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 208000031226 Hyperlipidaemia Diseases 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 241000522254 Cassia Species 0.000 claims description 10
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 230000002421 anti-septic effect Effects 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000012567 medical material Substances 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 239000011550 stock solution Substances 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 11
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 230000001717 pathogenic effect Effects 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 240000001745 Rheum palmatum Species 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 230000003203 everyday effect Effects 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 208000009205 Tinnitus Diseases 0.000 description 3
- 208000012886 Vertigo Diseases 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 201000005577 familial hyperlipidemia Diseases 0.000 description 3
- 230000003516 hyperlipidaemic effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 231100000889 vertigo Toxicity 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- -1 triacylglycerol lipid Chemical class 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a Chinese medicine oral fluid containing cattail pollen for relieving hyperlipoidemia, which is prepared by traditional Chinese medicine in part by weight: 30 to 50 parts of Chinese rhubarb, 50 to 100 parts of semen cassiae, 150 to 300 parts of cattail pollen, 150 to 300 parts of fruit of glossy privet and 150 to 300 parts of mulberry. The Chinese medicine oral fluid has the characteristics that treatment effect on patients is good, the toxic and side effects are small, the effects of treating both principal and secondary aspects of disease, strengthening the healthy energy not to lag the pathogenic factor, and eliminating the pathogenic factor not to injury the healthy energy are served, and the cost is low, thereby being worthy of clinical popularization and application.
Description
Technical field
The present invention relates to a kind of technical field of Chinese medicines, relate in particular to a kind of be used to alleviate hyperlipidemia Pollen Typhae Chinese medicine oral liquid and method for preparing.
Background technology
Human serum cholesterol that a variety of causes causes and triacylglycerol lipid compositions such as (triglyceride) are called hyperlipemia when being higher than normal value.About the standard of hyperlipemia, still there is not unified regulation at present in the world, advise being below serum total cholesterol (TC)≤5.17mmol/L (200mg/dl) proper level in China's dyslipidemia control suggestion; Adult's serum levels of triglyceride (TG) proper level is≤below the 1.69mmol/L (150mg/dl), surpasses this standard and is hyperlipemia.Hyperlipidemia belongs to the traditional Chinese medical science " expectorant is turbid ", " blood stasis " category.The traditional Chinese medical science is summarised as weakened body resistance the cause of disease of primary disease and the domination of pathogen, and void is deficiency of both the liver and kidney, insufficiency of vital energy and blood, and it is unable to gasify, or dysfunction of the spleen in transportation, and water paddy can not turn to precise and tiny; Real be phlegm retention, accumulates in the turbid heresy of the stasis of blood, checks venation, and illiteracy is closed key clearly.Traditional Chinese medical science Chinese herbal medicine oneself by universally acknowledged be the precious treasure-houses of indispensable human medicine.Therefore characteristics such as adopting the means of Chinese medicine to treat hyperlipidaemic conditions, is a channel extremely leaved for development, and it is gentle that Chinese medicine has the property of medicine, applied widely are having its original effect aspect the hyperlipidemia treatment.
Summary of the invention
The purpose of this invention is to provide a kind of instant effect, curative effect ideal lastingly, and no side effects, the alleviation hyperlipidemia Pollen Typhae Chinese medicine oral liquid that cost is low.
For realizing above-mentioned purpose, the present invention realizes through following technical scheme: technical scheme of the present invention is:
Alleviating hyperlipidemia Pollen Typhae Chinese medicine oral liquid, is to be formed by following parts by weight of traditional Chinese medicines feedstock production:
Radix Et Rhizoma Rhei 30-50 part, Semen Cassiae 50-100 part, Pollen Typhae 150-300 part, Fructus Ligustri Lucidi 150-300 part, Fructus Mori 150-300 part.
Described alleviation hyperlipidemia Pollen Typhae Chinese medicine oral liquid is to be formed by following parts by weight of traditional Chinese medicines feedstock production:
50 parts of Radix Et Rhizoma Rhei, 100 parts of Semen Cassiaes, 300 parts of Pollen Typhaes, 300 parts of Fructus Ligustri Lucidi, 300 parts in Fructus Mori.
The method for preparing of described alleviation hyperlipidemia Pollen Typhae Chinese medicine oral liquid, concrete steps are following
Get 50 parts of Radix Et Rhizoma Rhei, 100 parts of Semen Cassiaes, 300 parts of Pollen Typhaes, 300 parts of Fructus Ligustri Lucidi, 300 parts in Fructus Mori, water decocts secondary, and the 8-10 that each water consumption is a medical material weight doubly measures, and decocts secondary; Each l-2 hour, filter, filtrating is condensed into and surveys relative density at 60-65 ℃ is the clear paste of 1.10-1.25, to contain amount of alcohol be 60% to making to add ethanol; Stir, left standstill 24 hours, filter, get filtrate recycling ethanol; Be condensed into the extractum that contains solid weight 65-67%, add sucrose 20%, refined honey 12%, antiseptic 1-3%, stock solution embedding, irradiation sterilization; Packed products is processed oral liquid, promptly gets.
Usage and consumption: oral, the each 20ml of medicine of the present invention, every day 3 times, be 1 course of treatment half an hour all around after meal.This Chinese medicine oral liquid characteristics are that the patient is fully recovered is effective, and toxic and side effects is little, play treating both the principal and secondary aspects of a disease, set upright evil, the eliminating evil positive effect of not hindering that do not stagnate, and cost is low, is worth clinical application.
In the raw material of Chinese medicine of the present invention, Radix Et Rhizoma Rhei: bitter, cold, return stomach, large intestine, liver, spleen channel to attack stagnant, clearing away damp-heat, pathogenic fire purging, removing heat from blood, blood stasis dispelling, detoxifcation; Semen Cassiae: sweet, bitter, be slightly cold, return large intestine channel, liver heat removing and eyesight improving, loosening bowel to relieve constipation; Pollen Typhae: sweet, flat, return liver, pericardium channel, hemostasis, blood stasis dispelling, treating stranguria; Fructus Ligustri Lucidi: sweet, bitter, cool, return liver, kidney channel, nourishing the liver and kidney, black hair makes eye bright; Fructus Mori: sweet, sour, cold, GUIXIN, liver, kidney channel, are promoted the production of body fluid and are moisturized at the YIN nourishing of enriching blood; The merit that all medicines are played the spleen strengthening and damp drying, purging heat to relax the bowels, removing mass clots absorbing altogether.The outstanding effect of this medicine is to have no side effect, and remission rate is high, has fundamentally removed patient's misery.
The specific embodiment
EXAMPLE l:
Raw material of Chinese medicine: 50 parts of Radix Et Rhizoma Rhei, 100 parts of Semen Cassiaes, 300 parts of Pollen Typhaes, 300 parts of Fructus Ligustri Lucidi, 300 parts in Fructus Mori.
Method for making: get 50 parts of Radix Et Rhizoma Rhei, 100 parts of Semen Cassiaes, 300 parts of Pollen Typhaes, 300 parts of Fructus Ligustri Lucidi, 300 parts in Fructus Mori, water decocts secondary, and the 8-10 that each water consumption is a medical material weight doubly measures, and decocts secondary; Each l-2 hour, filter, filtrating is condensed into and surveys relative density at 60-65 ℃ is the clear paste of 1.10-1.25, to contain amount of alcohol be 60% to making to add ethanol; Stir, left standstill 24 hours, filter, get filtrate recycling ethanol; Be condensed into the extractum that contains solid weight 65-67%, add sucrose 20%, refined honey 12%, antiseptic 1-3%, stock solution embedding, irradiation sterilization; Packed products is processed oral liquid, promptly gets.
Usage and consumption: oral, the each 20ml of medicine of the present invention, every day 3 times, be 1 course of treatment half an hour all around after meal.
Embodiment 2:
Raw material of Chinese medicine: 40 parts of Radix Et Rhizoma Rhei, 75 parts of Semen Cassiaes, 225 parts of Pollen Typhaes, 225 parts of Fructus Ligustri Lucidi, 225 parts in Fructus Mori.
Method for making: get 40 parts of Radix Et Rhizoma Rhei, 75 parts of Semen Cassiaes, 225 parts of Pollen Typhaes, 225 parts of Fructus Ligustri Lucidi, 225 parts in Fructus Mori, water decocts secondary, and the 8-10 that each water consumption is a medical material weight doubly measures, and decocts secondary; Each l-2 hour, filter, filtrating is condensed into and surveys relative density at 60-65 ℃ is the clear paste of 1.10-1.25, to contain amount of alcohol be 60% to making to add ethanol; Stir, left standstill 24 hours, filter, get filtrate recycling ethanol; Be condensed into the extractum that contains solid weight 65-67%, add sucrose 20%, refined honey 12%, antiseptic 1-3%, stock solution embedding, irradiation sterilization; Packed products is processed oral liquid, promptly gets.
Usage and consumption: oral, the each 20ml of medicine of the present invention, every day 3 times, be 1 course of treatment half an hour all around after meal.
Embodiment 3:
Raw material of Chinese medicine: 30 parts of Radix Et Rhizoma Rhei, 50 parts of Semen Cassiaes, 150 parts of Pollen Typhaes, 150 parts of Fructus Ligustri Lucidi, 150 parts in Fructus Mori.
Method for making: get 30 parts of Radix Et Rhizoma Rhei, 50 parts of Semen Cassiaes, 150 parts of Pollen Typhaes, 150 parts of Fructus Ligustri Lucidi, 150 parts in Fructus Mori, water decocts secondary, and the 8-10 that each water consumption is a medical material weight doubly measures, and decocts secondary; Each l-2 hour, filter, filtrating is condensed into and surveys relative density at 60-65 ℃ is the clear paste of 1.10-1.25, to contain amount of alcohol be 60% to making to add ethanol; Stir, left standstill 24 hours, filter, get filtrate recycling ethanol; Be condensed into the extractum that contains solid weight 65-67%, add sucrose 20%, refined honey 12%, antiseptic 1-3%, stock solution embedding, irradiation sterilization; Packed products is processed oral liquid, promptly gets.
Usage and consumption: oral, the each 20ml of medicine of the present invention, every day 3 times, be 1 course of treatment half an hour all around after meal.
Embodiment 4:
Clinical observation
L, one data:
Patient's 60 examples, 30-40 years old 12 age example, 40-50 years old 20 example, 28 examples more than 50 years old.
2, diagnostic criteria:
Light-duty hyperlipidemia morbidity l 1 years, the patient is dizzy, muddled, top-heavy, limbs fatigue, drowsiness, dreaminess is tested inspection through sanguification, extraordinary value that blood lipids index is slight.
Heavy hyperlipidemia morbidity 3-8 years, patient's diet poor appetite, weak all over, fidgety irritability, the night sweat bitter taste, dry pharynx, dryness of the tongue, nose heave desire is fallen, symptoms such as grogginess, the extraordinary value of lipid examination index height is obvious.
3, Therapeutic Method: the each 20ml of oral medicine of the present invention, every day 3 times, be 1 course of treatment half an hour all around after meal, a light-duty course of treatment, heavy two courses of treatment.
4, efficacy assessment standard:
Produce effects: light, heavy hyperlipidemia this disease symptoms of patient after treating disappears, and it is normal that patient's body constitution is recovered, and through laboratory examination, in the blood fat normal value, follows up a case by regular visits to 1 years no recidivists of l.
Take a turn for the better: the hyperlipidemia symptom progressively alleviates or disappears, and the patient feels good, and it is normal that body constitution is recovered basically.
Invalid: as not reach improvement standard person.
5, therapeutic outcome:
In the treatment of a course of treatment, with light-duty hyperlipemic patients 30 examples of Drug therapy of the present invention, produce effects 20 examples, 7 examples that take a turn for the better, invalid 3 examples, total effective rate 90%;
In the treatment of two courses of treatment, with heavy hyperlipemic patients 30 examples of Drug therapy of the present invention, produce effects 18 examples, 10 examples that take a turn for the better, invalid 2 examples, total effective rate is 93.3%.
Embodiment 5:
Model case: Wei, 52 years old, man, conscious frequent feel headache; Vertigo and tinnitus has numbness during extremity, the waist knee joint is aching and limp unable, and dysphoria with smothery sensation is uneasy; By hospital diagnosis is hyperlipidemia, and cholesterol and triglyceride exceed normal three times, takes the each 20ml of invention medicine; Every day 3 times, three the course of treatment state of an illness blood fat return to normal level, complication complete obiterations such as headache and dizzy.
Embodiment 6:
Model case: leaf, 59 years old, woman, headache; Vertigo and tinnitus has numbness during extremity, the waist knee joint is aching and limp unable; By hospital diagnosis is hyperlipidemia, takes the each 20ml of invention medicine, every day 3 times; Four the course of treatment state of an illness blood fat return to normal level, the headache, vertigo and tinnitus, etc. the complication complete obiteration.
Claims (3)
1. alleviate hyperlipidemia Pollen Typhae Chinese medicine oral liquid, it is characterized in that: be to form by following parts by weight of traditional Chinese medicines feedstock production:
Radix Et Rhizoma Rhei 30-50 part, Semen Cassiae 50-100 part, Pollen Typhae 150-300 part, Fructus Ligustri Lucidi 150-300 part, Fructus Mori 150-300 part.
2. according to the described alleviation hyperlipidemia of claim l Pollen Typhae Chinese medicine oral liquid, it is characterized in that: be to form by following parts by weight of traditional Chinese medicines feedstock production:
50 parts of Radix Et Rhizoma Rhei, 100 parts of Semen Cassiaes, 300 parts of Pollen Typhaes, 300 parts of Fructus Ligustri Lucidi, 300 parts in Fructus Mori.
3. according to the method for preparing of the described alleviation hyperlipidemia of claim l Pollen Typhae Chinese medicine oral liquid, it is characterized in that: concrete steps are following
Get 50 parts of Radix Et Rhizoma Rhei, 100 parts of Semen Cassiaes, 300 parts of Pollen Typhaes, 300 parts of Fructus Ligustri Lucidi, 300 parts in Fructus Mori, water decocts secondary, and the 8-10 that each water consumption is a medical material weight doubly measures, and decocts secondary; Each l-2 hour, filter, filtrating is condensed into and surveys relative density at 60-65 ℃ is the clear paste of 1.10-1.25, to contain amount of alcohol be 60% to making to add ethanol; Stir, left standstill 24 hours, filter, get filtrate recycling ethanol; Be condensed into the extractum that contains solid weight 65-67%, add sucrose 20%, refined honey 12%, antiseptic 1-3%, stock solution embedding, irradiation sterilization; Packed products is processed oral liquid, promptly gets.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210182131.7A CN102670869B (en) | 2012-06-04 | 2012-06-04 | Chinese medicine oral fluid containing cattail pollen for relieving hyperlipoidemia and preparing method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210182131.7A CN102670869B (en) | 2012-06-04 | 2012-06-04 | Chinese medicine oral fluid containing cattail pollen for relieving hyperlipoidemia and preparing method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102670869A true CN102670869A (en) | 2012-09-19 |
| CN102670869B CN102670869B (en) | 2014-01-08 |
Family
ID=46803854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210182131.7A Expired - Fee Related CN102670869B (en) | 2012-06-04 | 2012-06-04 | Chinese medicine oral fluid containing cattail pollen for relieving hyperlipoidemia and preparing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102670869B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105125637A (en) * | 2015-09-30 | 2015-12-09 | 河南行知专利服务有限公司 | Preparing method for flower traditional Chinese medicinal material decoction-free preparation and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1367001A (en) * | 2002-02-03 | 2002-09-04 | 赵晓东 | Capsule for reducing blood-lipid and preventing thrombosis |
| CN1682936A (en) * | 2005-02-25 | 2005-10-19 | 石家庄四药有限公司 | Medicinal composition for treating hyperlipemia and its preparing method |
-
2012
- 2012-06-04 CN CN201210182131.7A patent/CN102670869B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1367001A (en) * | 2002-02-03 | 2002-09-04 | 赵晓东 | Capsule for reducing blood-lipid and preventing thrombosis |
| CN1682936A (en) * | 2005-02-25 | 2005-10-19 | 石家庄四药有限公司 | Medicinal composition for treating hyperlipemia and its preparing method |
Non-Patent Citations (1)
| Title |
|---|
| 黄融琪等: "探讨高脂血症的饮食治疗", 《药膳食疗》, no. 08, 30 August 2002 (2002-08-30), pages 4 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105125637A (en) * | 2015-09-30 | 2015-12-09 | 河南行知专利服务有限公司 | Preparing method for flower traditional Chinese medicinal material decoction-free preparation and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102670869B (en) | 2014-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102441081B (en) | Medicament for treating gout and its preparation method | |
| CN103432475B (en) | Traditional Chinese medicine composition for treating allergic rhinitis and preparation method thereof | |
| CN101559195A (en) | Epilepsy therapy capsule and preparation method thereof | |
| CN101011483B (en) | Chinese medicinal formulation for treating children's digestive system disease and its preparation method | |
| CN101284114A (en) | Medicine for treating rheumatism and rheumatoid disease | |
| CN105250776A (en) | Traditional Chinese medicine honeyed pills for treating xerophthalmia and preparation method thereof | |
| CN103127253A (en) | Chinese medicinal capsules for treating catagmatic blood stasis and preparation method thereof | |
| CN102805817B (en) | Medicine for treating rheumatism and rheumatoid diseases | |
| CN105028772A (en) | Health care tea used for reducing blood fat and preparation method for health care tea | |
| CN1541676A (en) | Health care medicine for enriching blood in puerperium and its preparation and uses | |
| CN102670869B (en) | Chinese medicine oral fluid containing cattail pollen for relieving hyperlipoidemia and preparing method thereof | |
| CN104524464A (en) | Traditional Chinese medicine preparation for treating hyperactivity and preparation method of traditional Chinese medicine preparation | |
| CN103142897B (en) | Medicine used after esophageal achalasia operation | |
| CN101797371B (en) | Drug combination for weight-reducing massage | |
| CN111450152A (en) | Kidney-tonifying blood-activating collateral-dredging formula and preparation method thereof | |
| CN109172686A (en) | The Chinese medicine composition and its preparation method and application for treating senile skin pruritus | |
| CN103893488A (en) | Chinese medicine preparation for treating migraine and preparation method thereof | |
| CN103638232B (en) | One treats rheumatismal Chinese medicine composition | |
| CN109010494A (en) | A kind of Chinese medicine and preparation method thereof for treating rheumatoid arthritis | |
| CN108853390A (en) | The Chinese materia medica preparation and preparation method thereof for treating gonitis | |
| CN103751488B (en) | A kind of medicine for the treatment of high-sensitivity condition after neurosurgery operation | |
| CN103751489B (en) | A kind of preparation method for the treatment of the postoperative pain medication of neurosurgery | |
| CN118001341B (en) | A Chinese medicinal composition and unguent for treating allergic diseases caused by hypoimmunity such as allergic rhinitis, and its preparation method | |
| CN114699363B (en) | Traditional Chinese medicine wax mud for osteoarthritis and preparation method thereof | |
| CN102552742B (en) | Medicine for treating scapulohumeral periarthritis and rheumatism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: YIN ZHULIANG Free format text: FORMER OWNER: HUANG YUN Effective date: 20140526 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 523120 DONGGUAN, GUANGDONG PROVINCE TO: 523000 DONGGUAN, GUANGDONG PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20140526 Address after: 523000 Guangdong city of Dongguan province Dongcheng District Dongcheng style pedestrian street A elegant department Patentee after: Yin Zhuliang Address before: 523120 A elegant department store, Dongcheng style walking street, Dongguan, Dongcheng District, Guangdong Patentee before: Huang Yun |
|
| CB03 | Change of inventor or designer information |
Inventor after: Wang Lijuan Inventor before: Huang Yun |
|
| CB03 | Change of inventor or designer information | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170629 Address after: 276000 No. 235 Lianhua Road, Pingyi County, Shandong, Linyi Patentee after: Wang Lijuan Address before: 523000 Guangdong city of Dongguan province Dongcheng District Dongcheng style pedestrian street A elegant department Patentee before: Yin Zhuliang |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140108 Termination date: 20180604 |